ABVC (ABVC BioPharma) PS Ratio: (As of Jun. 26, 2026)


ABVC ABVC BioPharma Inc ABVC
17 GF Score
Price $1.48
GF Value $0.87
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is ABVC BioPharma PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ABVC BioPharma's share price is $1.475. ABVC BioPharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Hence, ABVC BioPharma's PS Ratio for today is .

The historical rank and industry rank for ABVC BioPharma's PS Ratio or its related term are showing as below:

During the past 13 years, ABVC BioPharma's highest PS Ratio was 359997.12. The lowest was 3.63. And the median was 146.52.

ABVC's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.165
* Ranked among companies with meaningful PS Ratio only.

ABVC BioPharma's Revenue per Sharefor the three months ended in Mar. 2026 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

During the past 12 months, the average Revenue per Share Growth Rate of ABVC BioPharma was -100.00% per year.

During the past 13 years, ABVC BioPharma's highest 3-Year average Revenue per Share Growth Rate was -8.60% per year. The lowest was -77.50% per year. And the median was -40.00% per year.

Back to Basics: PS Ratio


ABVC BioPharma  (NAS:ABVC) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


ABVC BioPharma PS Ratio Related Terms


ABVC BioPharma PS Ratio Historical Data

* Premium members only.

The historical data trend for ABVC BioPharma's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABVC BioPharma PS Ratio Chart

ABVC BioPharma Annual Data
Trend Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 238.73 20.42 33.14 13.41 0.00

ABVC BioPharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.85 71.77 0.00 0.00 0.00

ABVC vs GRDX, INMB, ALGS: PS Ratio Comparison

For the Biotechnology subindustry, ABVC BioPharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABVC BioPharma PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABVC BioPharma's PS Ratio distribution charts can be found below:

* The bar in red indicates where ABVC BioPharma's PS Ratio falls into.


ABVC
17GF Score
ABVC BioPharma Inc ABVC
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABVC BioPharma PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

ABVC BioPharma's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.475/0
=

ABVC BioPharma's Share Price of today is $1.475.
ABVC BioPharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Is ABVC BioPharma (ABVC) Overvalued in 2026?

Based on GuruFocus' analysis, ABVC BioPharma stock appears to be overvalued. The current stock price of $1.48 is trading 69.5% above its estimated GF Value™ of $0.87. GuruFocus considers ABVC BioPharma to be Significantly Overvalued.

Key valuation signals for ABVC:

  • PS Ratio:
  • GF Value™: $0.87 vs. price of $1.48 (69.5% above fair value)
  • GF Score™: 17/100 with 1 warning sign

No single metric tells the full story. See the ABVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ABVC BioPharma Business Description

Address 44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
17GF Score

Get the complete analysis for ABVC

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.48
Price
$0.87
GF Value